1 - Military Medical Research Center, Bucharest, Romania
2 - "Titu Maiorescu” University, Bucharest, Romania
Received: October 23, 2019
Accepted: February 13, 2020
Given the continuous growth of the bacterial resistance phenomenon, the appropriate choice of antibiotherapy represents an important step in the treatment and prophylaxis of infectious diseases. Depending on the symptomatology, the dose required for the effective treatment of an infection may vary. Inadequate dosing not only reduces the effectiveness of the antibiotic, but also promotes the emergence of resistant bacterial strains. Also, too high of a dose increases the toxic side effects of antibiotics. Therefore, a personalised antibiotherapy according to: the patient’s clinical status, body mass, associated chronic diseases, etc. represents a promising approach in the treatment of infectious diseases. The purpose of this study is to present the most important current affairs regarding the emergence of new antibiotics, the maximum doses recommended by the latest version of the “European Committee on Antimicrobial Susceptibility Testing” (EUCAST – version 9/2019) and providing an indication on whether these antibiotics are used in Romania.
Ordeanu, V., Ionescu, L.E., Dumitrescu, V.G., Pricop, R.G., Neagu, R., & Popescu, D.M. (2025). Antibiotherapy: latest current affairs – state of the art 2019. Romanian Journal of Military Medicine, 123(2), 98-101.
Ordeanu V, Ionescu LE, Dumitrescu VG, Pricop RG, Neagu R, Popescu DM. Antibiotherapy: latest current affairs – state of the art 2019. Rom J Mil Med. 2025;123(2):98-101.
Ordeanu, V., Ionescu, L.E., Dumitrescu, V.G., Pricop, R.G., Neagu, R. & Popescu, D.M. 2025, 'Antibiotherapy: latest current affairs – state of the art 2019', Romanian Journal of Military Medicine, vol. 123, no. 2, pp. 98-101.
